Bigul

DIVI'S LABORATORIES LTD. - 532488 - 30Th Annual General Meeting Of The Company To Be Held On 14 September, 2020

We hereby inform that the 30th Annual General Meeting of the Company is scheduled to be held on Monday, 14 September, 2020 at 10.00 A.M. IST through video conferencing (VC) / other audio visual means (OAVM). The Notice of the 30th Annual General Meeting and the standalone and consolidated financial statements for the financial year 2019-20, along with Board''s Report, Auditors'' Report and other documents required to be attached thereto (i.e. Annual Report 2019-20) will be sent to all shareholders whose email IDs are registered with the Company's RTA / Depositories and will also be made available on the Company''s website at https://www.divislabs.com/investor-relations/reports-and-filings/annual-reporting/ in due course. Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (LODR) Regulations, 2015, the Register of Members and Share Transfer books will remain closed from Tuesday, 08 September, 2020 to Monday, 14 September, 2020 (both days inclusive).
17-08-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed copies of newspaper advertisement to shareholders of the Company regarding registration/updation of e-mail address. This notice is published on 13 August, 2020 in the following newspapers: Financial Express (English Daily) Andhra Prabha (Telugu Daily)
13-08-2020
Bigul

Earnings Call Transcript - Q1FY21 for Divis Laboratories

Conference Call with Divis Lab Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.
10-08-2020

Divis Labs shares rally 12% as Q1 profit spikes 81%; HSBC raises target to Rs 2,755

The pharma company reported 80.61 percent rise in consolidated net profit at Rs 492.06 crore for June quarter 2020 mainly on account of robust sales.
10-08-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Schedule Of Earnings Conference Call Q1 FY21 To Be Held On 08 August, 2020

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings conference call to be held on 08 August, 2020.
05-08-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended 30 June, 2020

DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2020 ,inter alia, to consider and approve Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, 08 August, 2020, inter-alia, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended 30 June, 2020. As intimated earlier, the Trading Window for dealing in securities of the Company has been closed from 01 July, 2020 till 48 hours after the declaration of financial results as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and records.
29-07-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Shareholding for the Period Ended June 30, 2020

Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here
16-07-2020
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from KFin Technologies Private Limited (formerly known as Karvy Fintech Private Limited), Registrar & Share Transfer Agent of the Company dated 09 July,2020 for the quarter ended 30 June, 2020. This is for your information and records
15-07-2020
Next Page
Close

Let's Open Free Demat Account